Class of severely disabled Medicaid recipients challenged Florida’s decision to deny coverage of a prescription drug, Neurontin, for medically accepted indications that were cited in congressionally-recognized drug compendia, including neuropathic pain and certain psychiatric disorders, in violation of the Medicaid Act.
Section 1557 generally prohibits different treatment (also referred to as “intentional discrimination”) and discriminatory effects (also referred to as…
